Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Psilocybin Therapy for Depression in Parkinson's Disease — Stella

Home/Parkinson Disease/Psilocybin Therapy for Depression in Parkinson's Disease

View on ClinicalTrials.gov

Recruiting

Back to Parkinson Disease trials

Psilocybin Therapy for Depression in Parkinson's Disease

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of California, San Francisco, San Francisco, California

Key details

Phase

Safety & dosing

Sponsor

Joshua Woolley, MD, PhD

Enrollment target

~60 participants

Started

August 2024

Primary completion

June 2027

Age range

40 Years – 80 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.